Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors

被引：7
作者：
Deharo, Pierre [1 ,2 ,3 ]
Pankert, Mathieu [1 ,2 ,3 ]
Quilici, Jacques [1 ,2 ,3 ]
Bonnet, Guillaume [1 ,2 ,3 ]
Bassez, Clemence [1 ,3 ]
Verdier, Valentine [5 ]
Morange, Pierre [2 ,3 ,4 ]
Alessi, Marie-Christine [2 ,3 ,4 ]
Bonnet, Jean-Louis [1 ,2 ,3 ]
Cuisset, Thomas [1 ,2 ,3 ]
机构：
[1] CHU Timone, Dept Cardiol, F-13385 Marseille, France
[2] INSERM, UMR1062, Nutr Obes & Risk Thrombosis, F-13385 Marseille, France
[3] Aix Marseille Univ, Fac Med, F-13385 Marseille, France
[4] CHU Timone, Lab Hematol, F-13385 Marseille, France
[5] Assistance Publ Hop Marseille, EMAI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷
关键词：
Chronic kidney disease; Platelet reactivity; P2Y12; blockers; Acute coronary syndromes; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; CLOPIDOGREL; PRASUGREL; REACTIVITY; GUIDELINES;
D O I：
10.1016/j.ijcard.2015.02.077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：428 / 430
页数：3
相关论文
共 50 条
  • [1] P2Y12 Inhibitors in Patients With Chronic Kidney Disease The Known Unknown
    Gurm, Hitinder S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (20) : 2026 - 2028
  • [2] P2Y12 platelet inhibition in clinical practice
    Damman, Peter
    Woudstra, Pier
    Kuijt, Wichert J.
    de Winter, Robbert J.
    James, Stefan K.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (02) : 143 - 153
  • [3] Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors
    Adamski, Piotr
    Kozinski, Marek
    Ostrowska, Malgorzata
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Paciorek, Przemyslaw
    Grzesk, Grzegorz
    Kubica, Jacek
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 224 - 242
  • [4] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
  • [5] Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors
    Thomas, Mark R.
    Storey, Robert F.
    VASCULAR PHARMACOLOGY, 2016, 84 : 25 - 27
  • [6] New P2Y12 Inhibitors
    Cattaneo, Marco
    CIRCULATION, 2010, 121 (01) : 171 - 179
  • [7] Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study
    Deharo, Pierre
    Quilici, Jacques
    Bonnet, Guillaume
    Grosdidier, Charlotte
    Morange, Pierre
    Alessi, Marie-Christine
    Bonnet, Jean-Louis
    Cuisset, Thomas
    PLATELETS, 2016, 27 (08) : 791 - 795
  • [8] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [9] P2Y12 platelet inhibition in clinical practice
    Peter Damman
    Pier Woudstra
    Wichert J. Kuijt
    Robbert J. de Winter
    Stefan K. James
    Journal of Thrombosis and Thrombolysis, 2012, 33 : 143 - 153
  • [10] Comparative efficacy and safety of oral P2Y12 inhibitors for patients with chronic kidney disease and acute coronary syndrome: a network meta-analysis
    Farmakis, Ioannis T.
    Doundoulakis, Ioannis
    Zafeiropoulos, Stefanos
    Pagiantza, Areti
    Apostolidou-Kiouti, Fani
    Kourti, Olga
    Kassimis, George
    Haidich, Anna-Bettina
    Karvounis, Haralambos
    Giannakoulas, George
    HELLENIC JOURNAL OF CARDIOLOGY, 2022, 63 : 40 - 65
12345